Viewing Study NCT06530212



Ignite Creation Date: 2024-10-25 @ 8:02 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06530212
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-17

Brief Title: Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass
Sponsor: None
Organization: None

Study Overview

Official Title: Sleeve Gastrectomy With Jejuno-ieal Bypass
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: sleeve gastrectomy with jejunoileal bypass SGJIB is a novel technique for the surgical treatment of obesity The aim of the study is to compare this maneuver with single anastomosis sleeve jejunal bypass SAS-JB
Detailed Description: 200 patients will be randomly divided into to equal Group 1 will be operated by sleeve gastrectomy with jejunoileal bypass with the anastomosis between the jejunum at about 100 cm from the duodeno-jejunal flexure and the ileum at 250 cm from the ileocaecal junction and group 2 will be operated by single anastomosis sleeve jejunal bypass SAS-JB with biliary limb equal one third of total intestinal length

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None